Loading...

Endonovo Therapeutics, Inc.

ENDV•PNK
Healthcare
Biotechnology
$0.00
$0.00(9900.000%)
U.S. Market is Open • 14:02

Endonovo Therapeutics, Inc. (ENDV) Stock Overview

Explore Endonovo Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap15.9K
P/E Ratio-0.03
EPS (TTM)$-0.01
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

ENDV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Endonovo Therapeutics, Inc. (ENDV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.60, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 15.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4900.00%
5-Day Change
0.00%
1-Month Change
-50.00%
3-Month Change
0.00%
6-Month Change
-50.00%
Year-to-Date (YTD) Change
-50.00%
1-Year Change
-50.00%
3-Year Change
-99.66%
5-Year Change
-99.85%
All-Time (Max) Change
-100.00%

Contact Information

https://www.endonovo.com
800 489 4774
6320 Canoga Avenue, Woodland Hills, CA, 91367

Company Facts

1 Employees
IPO DateNov 15, 2012
CountryUS
Actively Trading

Frequently Asked Questions